Suchergebnisse - "Woloshin, Steven"

PubPharm (7)

1

A National Survey of the Frequency of Drug Company Detailing Visits and Free Sample Closets in Practices Delivering Primary Care

enthalten in: JAMA internal medicine | 2020

von King, A. | Schwartz, L. | Woloshin, S.

CommentIn: JAMA Intern Med. 2020 Apr 1;180(4):595-596. - PMID 31985770

2

Medical Marketing in the United States, 1997-2016

enthalten in: JAMA | 2019

von Schwartz, L. | Woloshin, S.

CommentIn: JAMA. 2019 Jan 1;321(1):40-41. - PMID 30620354

3

Methodological approaches to evaluate the impact of FDA drug safety communications

enthalten in: Drug safety | 2015

von Kesselheim, A. | Campbell, E. | Schneeweiss, S. | +10

ErratumIn: Drug Saf. 2015 Sep;38(9):845. - PMID 26201399

4

The Drug Facts Box : Improving the communication of prescription drug information

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2013

von Schwartz, L. | Woloshin, S.

5

Getting to better prescription drug information

enthalten in: Journal of general internal medicine | 2012

von Woloshin, S. | Schwartz, L.

CommentOn: J Gen Intern Med. 2012 Dec;27(12):1707-13. - PMID 22451015

6

Communicating uncertainties about prescription drugs to the public : a national randomized trial

enthalten in: Archives of internal medicine | 2011

von Schwartz, L. | Woloshin, S.

CommentIn: Arch Intern Med. 2011 Sep 12;171(16):1468-9. - PMID 21911630

7

Using a drug facts box to communicate drug benefits and harms : two randomized trials

enthalten in: Annals of internal medicine | 2009

von Schwartz, L. | Woloshin, S. | Welch, H.

CommentIn: Ann Intern Med. 2009 Apr 21;150(8):563-4. - PMID 19240226

1
[1]